Search

everythinglearnresearchcommunity

for

Search:↓

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Understanding where cancer cells come from helps create better prevention and treatment methods.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Tamoxifen caused hair loss in a 52-year-old woman.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Hair loss gene linked to prostate issues.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Some breast cancer chemotherapy can cause permanent hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.